Abstract:Background: Most randomized controlled trials with a time-to-event outcome are designed assuming proportional hazards (PH) of the treatment effect. The sample size calculation is based on a logrank test. However, non-proportional hazards are increasingly common. At analysis, the estimated hazards ratio with a confidence interval is usually presented. The estimate is often obtained from a Cox PH model with treatment as a covariate. If non-proportional hazards are present, the logrank and equivalent Cox tests may lose power. To safeguard power, we previously suggested a 'joint test' combining the Cox test with a test of non-proportional hazards. Unfortunately, a larger sample size is needed to preserve power under PH. Here, we describe a novel test that unites the Cox test with a permutation test based on restricted mean survival time. Methods: We propose a combined hypothesis test based on a permutation test of the difference in restricted mean survival time across time. The test involves the minimum of the Cox and permutation test P-values. We approximate its null distribution and correct it for correlation between the two P-values. Using extensive simulations, we assess the type 1 error and power of the combined test under several scenarios and compare with other tests. We investigate powering a trial using the combined test. Results: The type 1 error of the combined test is close to nominal. Power under proportional hazards is slightly lower than for the Cox test. Enhanced power is available when the treatment difference shows an 'early effect', an initial separation of survival curves which diminishes over time. The power is reduced under a 'late effect', when little or no difference in survival curves is seen for an initial period and then a late separation occurs. We propose a method of powering a trial using the combined test. The 'insurance premium' offered by the combined test to safeguard power under non-PH represents about a single-digit percentage increase in sample size. Conclusions: The combined test increases trial power under an early treatment effect and protects power under other scenarios. Use of restricted mean survival time facilitates testing and displaying a generalized treatment effect.

PIN67 Extended Cox Model Analysis with Non-Proportional Hazards Applied in Real-World Observational Data

A penalized Cox proportional hazards model with multiple time-varying exposures

Bayesian Dose Finding by Jointly Modelling Toxicity and Efficacy As Time-To-Event Outcomes

Temporal Changes in the Treatment Paradigm and Long-term Prognosis of Patients With Crohn's Disease: A Hospital-Based Cohort Study in China

Generating survival times using Cox proportional hazards models with cyclic time-varying covariates, with application to a multiple-dose monoclonal antibody clinical trial

Analysis of survival data with non-proportional hazards: A comparison of propensity score weighted methods

Blended Survival Curves: A New Approach to Extrapolation for Time-to-Event Outcomes from Clinical Trial in Health Technology Assessment

Estimating effects of time-varying exposures on mortality risk

Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated

Covariate-adjusted Survival Analyses in Propensity-Score Matched Samples: Imputing Potential Time-to-event Outcomes.

Posterior predictive treatment assignment methods for causal inference in the context of time-varying treatments

Comparison of baseline covariate adjustment methods for restricted mean survival time

A non-parametric proportional risk model to assess a treatment effect in time-to-event data

A nonparametric proportional risk model to assess a treatment effect in time‐to‐event data

Causal survival analysis: A guide to estimating intention-to-treat and per-protocol effects from randomized clinical trials with non-adherence

Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Voriconazole for Predicting the Clinical Outcomes of Adult Patients with Invasive Aspergillosis

Modeling the Causal Effect of Treatment Initiation Time on Survival: Application to HIV/TB Co-infection

Estimation of the causal effects of time-varying treatments in nested case-control studies using marginal structural Cox models

Covariate-adjusted Group Sequential Comparisons of Survival Probabilities

A two-step approach for analyzing time to event data under non-proportional hazards

Controlled comparison of a single high dose of oxprenolol with lorazepam on stress-induced physiological changes and on some psychophysiological variables [proceedings].